A global biotech wanted to analyse four APAC markets and assess their Digital Health ecosystem by exact criteria, to assess readiness and prioritise digital health resources and investments
Embarking on our PlayBook methodology, we enabled our client to study digital innovation readiness by reviewing user groups (patients), primary therapeutic areas, bio pharma partnerships, and in-depth profiles of 10 Digital Health ventures. This led to deeper market insights and franchise level market opportunity optimisation
| Number of countries | 4 |
| Number of Key TAs analysed | 4 |
| Number of ventures screened | 319 |
| Number of ventures shortlisted | 56 |
Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth
